Abstract
The systemic vasculitides are heterogeneous conditions of unknown etiology characterized by inflammation and necrosis of different sized blood vessels. Wegener’s Granulomatosis, microscopic polyangiitis, and Churg Strauss syndrome are associated with anti-neutrophil cytoplasmic antibodies and affect small and medium blood vessels. They are very rare in childhood and peak in the 65 to 70 year old age group. Wegener’s Granulomatosis appears to be more common in the North of Europe compared with the South. All are more common in whites compared with other populations. Genetic and environmental factors, including infection, drugs, and silica, are important in etiology. Giant cell arteritis is predominantly a disease of whites over the age of 50. It appears more common in individuals with Nordic descent. Incidence may be increasing over time and cyclical variation in disease may reflect an infectious etiology. Takayasu arteritis is a disease of the aorta and its branches, however pulmonary and cardiac arteries may be involved. Patients are usually under 40-years of age at presentation and there are no apparent differences in incidence or clinical characteristics/aortic involvement across the globe. Kawasaki disease (KD) and Henoch-Schonlein purpura are diseases of children and rarely affect adults. Both have been reported to be more common in Asians than whites. The incidence of KD is higher in Japan and China compared with other regions. No definite trigger factors have been found, but KD has been linked to infection, house dust mite and chemicals, and Henoch-Schonlein purpura to a pesticide and drugs.
References and Recommended Reading
Fries JF, Hunder GG, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification vasculitis: summary. Arthritis Rheum 1990, 33:1135–1136.
Jennette JC, Falk RJ, Andrassy K, et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187–192.
Hagen EC, Andrassy K, Csernok E, et al.: The diagnostic value of standardised assays for ANCA in idiopathic systemic vasculitis: results of an international collaborative study. Kidney Int 1998, 53:743–753. Results of an international collaborative study of the value of ANCA in the diagnosis of PSV.
Lane SE, Watts RA, Scott DGI: European Medicines Agency (EMEA) consensus classification of the primary systemic vasculitides (PSV) for epidemiological studies. Rheumatology 2005, 44(Suppl):abstract.
Watts RA, Koldingsnes W, Nossent H, et al.: Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001, 60:1156–1157.
Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL: Stable incidence of primary systemic vasculitides over five years: results from the German Vasculitis Register. Arthritis Rheum 2005, 53:93–99.
Gonzalez-Gay M, Garcia-Porrua C, Guerrero J, et al.: The epidemiology of the primary systemic vasculitides in Northwest Spain: implication of the Chapel Hill Consensus Conference Definitions. Arthritis Rheum 2003, 49:388–393.
Reinhold-Keller E, Zeidler A, Gutfleisch J, et al.: Giant cell arteritis is more prevalent in urban than rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology 2000, 39:1396–1402.
Mahr A, Guillevin L, Poissonnet M, Ayme S: Prevalence of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis and Churg Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51:92–99.
Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR: Incidence of Henoch Schonlein purpura, Kawasaki disease and rare vasculitides in children of different ethnic origins. Lancet 2002, 360:1197–1202. Study of the epidemiology of incidence of systemic vasculitis in childhood in an ethnic population.
Dolezalova P, Telekesova P, Nemcova D, Hoza J: Incidence of vasculitis in children in the Czech Republic: a 2-year prospective epidemiology survey. J Rheum 2004, 31:2295–2299.
Watts RA, Mooney J, Lane SE, Scott DGI: The incidence of primary systemic vasculitis—unchanged over 15 years. Arthritis Rheum 2004, 50(Suppl):S270.
Belostotsky VM, Shah V, Dillon MJ: Clinical features in 17 paediatric patients with Wegener’s granulomatosis. Paediatr Nephrol 2002, 17:754–761.
Harper L, Savage CO: ANCA-associated renal vasculitis at the end of the twentieth century-a disease of older patients. Rheumatology (Oxford) 2004, 44:495–501.
Lane SE, Watts RA, Scott DGI: Primary systemic vasculitis: clinical features and mortality. QJM 2005, 98:97–111.
Xin G, Zhao M-H, Wang H-Y: Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis. Clin Diagn Lab Immunol 2004, 11:559–562.
Lee S, Lawton JW: Heterogeneity of anti-PR3 associated disease in Hong Kong. Postgrad Med 2000, 76:287–288.
Li PK, Leung J, Lai FM, et al.: Use of antineutrophil cytoplasmic antibodies in diagnosing vasculitis in a Chinese patient population. Am J Nephrol 1994, 14:99–105.
El-Reshaid K, Varro J, Al Duwairi Q, et al.: Takayasu arteritis in Kuwait. J Trop Med Hyg 1995, 98:299–305.
Sivakumar MR, Chandrakantan A: The pattern of ANCA-associated vasculitis in India. Rheumatology 2001, 40(Suppl 1):124.
Fietta P: Systemic vasculitides: immunogenetics and familial clustering. Clin Exp Rheumatol 2004, 22:238–251. Recent review of genetic factors involved in the susceptibility, severity, and outcome of systemic vasculitis.
Westman K, Selga D, Isberg P-E, et al.: High proteinase 3 antineutrophil cytoplasmic antibody (ANCA) level measured by the capture ELISA method is associated with decreased patients survival in ANCA-associated vasculitis with renal involvement. J Am Soc Nephrol 2003, 14:2926–1933.
Tidman M, Olander R, Svalander C, Danielsson D: Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975–95: organ involvement, anti-neutrophil cytoplasmic antibody patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998, 244:133–141.
Lane SE, Watts RA, Bentham G, Scott DGI: Seasonal and periodic variation in primary systemic vasculitis in Norfolk Rheumatology 2002, 41(Suppl):abstract.
Falk RJ, Hogan S, Carey TS, Jeanette C: Clinical course of antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990, 113:656–663.
Somer T, Finegold S: Vasculitides associated with infections, immunization and antimicrobial drugs. Clin Infect Dis 1995, 20:1010–1036.
Tarvaert JW, Stegeman CA, Kallenberg CG: Silicon exposure and vasculitis. Curr Opin Rheumatol 1998, 10:12–17.
Lane SE, Watts RA, Bentham G, et al.: Do environmental factors play a significant role in the aetiology of primary systemic vasculitis?—a case control study. Arthritis Rheum 2003, 48:814–823. Case control study of environmental trigger factors of PSV with review of previous publications.
Hogan SL, Satterly KK, Dooley MA, et al.: Silica exposure in antineutrophil cytoplasmic antibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001, 12:134–142.
Duna GF, Cotch MF, Galperin C, et al.: Wegener’s Granulomatosis: role of environmental exposures. Clin Exp Rheumatol 1998, 16:669–674.
Pai P, Bone JM, Bell GM: Hydrocarbon exposure and glomerulonephritis due to systemic vasculitis. Nephrol Dial Transplant 1998, 13:1321–1323.
Cuadrado MJ, D’Cruz D, Lloyd M, et al.: Allergic disorders in systemic vasculitis: a case control study. Br J Rheumatol 1994, 33:749–753.
Slot M, Links T, Stegemen C, Tervaert J: Occurrence of anti-neutrophil cytoplasmic antibodies and associated vacsulitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term follow-up study. Arthritis Rheum 2005, 53:108–113.
Gross WL: Churg Strauss syndrome: update on recent developments. Curr Opin Rheumatol 2002, 14:11–14.
Nordberg C, Johanssen H, Petursdottir V, Nordberg E: The epidemiology of GCA: special reference to changes in the age of the population. Rheumatology 2003, 42:549–552.
Salvarani C, Crowson CS, O’Fallon WM, et al.: Reappraisal of the epidemiology of giant cell arteritis in Olmstead County, Minnesota, over a fifty-year period. Arthritis Rheum 2004, 51:264–268. Report of the incidence of GCA over prolonged period demonstrating cyclical pattern of disease.
Gonzalez-Gay M, Garcia-Porrua C, Amor-Dorado JC, et al.: Influence of age, sex and place of residence on the clinical expression of giant cell arteritis in North-West Spain. J Rheumatol 2003, 30:1548–1551.
Llorca J, Bringas-Bollada M, Amor-Dorado JC, et al.: Lack of association between altitude and incidence of giant cell arteritis in Northwest Spain. Clin Exp Rheumatol 2004, 22:270.
Haugeberg G, Irgens KA, Thomsen RS: No major differences in incidence of temporal arteritis in north and western Norway compared with reports from southern Norway. Scand J Rheumatol 2003, 32:318–319.
Rosso MG, Waxman J, Abdoh A, Serebro LH: Correlation between infection and the onset of giant cell arteritis syndrome. Arthritis Rheum 1995, 38:374–380.
Elling P, Olsson AT, Wiling H: Synchronous variations in the incidence of temporal arteritis and polymyalgia rheumatica in different regions in Denmark, association with epidemics of mycoplasma pneumoniae infection. J Rheumatology 1996, 23:112–119.
Hall S, Barr W, Lie JT, et al.: Takayasu arteritis: a study of 32 North American patients. Medicine 1985, 64:89–99.
Koide K: Takayasu arteritis in Japan. Heart Vessels 1992, 7:48–52.
Ureten K, Ozturk MA, Onat AM, et al.: Takayasu arteritis: results of a university hospital of 45 patients in Turkey. Int J Cardiol 2004, 96:259–264.
Rozo JC, Jefferies JL, Eidem BW, Cook PJ: Kawasaki disease in the adult: a case report and review of the literature. Tex Heart Inst J 2004, 31:160–164.
Yanagawa H, Nakamura Y, Yashiro M, et al.: Incidence of Kawasaki disease 1997–1998 in Japan. Paediatrics 2002, 107:E33.
Lynch M, Holman RC, Mulligan A, et al.: Kawasaki syndrome hospitalizations in Ireland, 1996 through 2000. Pediatr Infect Dis J 2003, 22:959–963.
Lue HC, Philip S, Chen M, et al.: Surveillanca of Kawasaki disease in Taiwan and review of the literature. Acta Paediatr Taiwan 2004, 45:8–14.
Lloyd AJ, Walker C, Wilkinson M: Kawasaki disease: is it caused by an infectious agent? Br J Biomed Sci 2001, 58:122–128.
Watts RA, Joliffe VA, Grattan CEH, et al.: Cutaneous vasculitis in a defined population—clinical and epidemiological associations. J Rheumatol 1998, 25:420–424.
Garcia Porrua C, Gonzalez Gay MMA: Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch Schonlein Purpura in adults. Semin Arthritis Rheum 1999, 28:404–412.
Yang Y-H, Hung C-F, Hsu C-R, et al.: A natiowide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan. Rheumatology (Oxford) 2005, 44:618–622.
Gonzalez-Gay MA, Calvino MC, Vazquez-Lopez, et al.: Implications of upper respiratory tract infections and drugs in the clinical spectrum of Henoch-Schonlein purpura in children. Clinial Exp Rheum 2004, 22:781–784.
Mohammad A, Jacobsson L, Segelmark M, Sturfelt F: Prevalence of small vessel vasculitis in Southern Sweden—preliminary report. Kid Blood Press Res 2003, 26:249–302.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lane, S.E., Watts, R. & Scott, D.G.I. Epidemiology of systemic vasculitis. Curr Rheumatol Rep 7, 270–275 (2005). https://doi.org/10.1007/s11926-005-0036-5
Issue Date:
DOI: https://doi.org/10.1007/s11926-005-0036-5